Skip to main content
Top
Published in: European Journal of Medical Research 1/2021

Open Access 01-12-2021 | Research

Differential hippocampal protein expression between normal mice and mice with the perioperative neurocognitive disorder: a proteomic analysis

Authors: Chuan Li, Jingzhu Li, He Tao, Jinghua Shan, Fanghao Liu, Xiyuan Deng, Yanan Lin, Xu Lin, Li Fu, Bin Wang, Yanlin Bi

Published in: European Journal of Medical Research | Issue 1/2021

Login to get access

Abstract

Objectives

To compare differential expression protein in hippocampal tissues from mice of perioperative neurocognitive disorder (PND) and normal control mice and to explore the possible mechanism of PND.

Methods

Mice were randomly divided into a PND group (n = 9) and a control group (n = 9).The mice in the PND group were treated with open tibial fracture with intramedullary fixation under isoflurane anesthesia, while the mice in the control group received pure oxygen without surgery. The cognitive functions of the two groups were examined using Morris water maze experiment, Open field test and Fear conditioning test. The protein expression of the hippocampus of mice was analyzed by high-performance liquid chromatography–mass spectrometry (HPLC–MS/MS). Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed to explore the principal functions of dysregulated proteins.

Results

A total of 21 proteins were differentially expressed between PND and control mice on days 1, 3, and 7 after the operation. These proteins were involved in many pathological processes, such as neuroinflammatory responses, mitochondrial oxidative stress, impaired synaptic plasticity, and neuronal cell apoptosis. Also, the dysregulated proteins were involved in MAPK, AMPK, and ErbB signaling pathways.

Conclusion

The occurrence of PND could be attributed to multiple mechanisms.
Literature
6.
go back to reference Szwed K, Bieliński M, Drozdz W, et al. Cognitive dysfunction after cardiac surgery. Psychiatr Pol. 2012;46(3):473–82.PubMed Szwed K, Bieliński M, Drozdz W, et al. Cognitive dysfunction after cardiac surgery. Psychiatr Pol. 2012;46(3):473–82.PubMed
11.
go back to reference Wisniewski JR, Zougman A, Nagaraj N, et al. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6:359–62.CrossRef Wisniewski JR, Zougman A, Nagaraj N, et al. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6:359–62.CrossRef
18.
go back to reference Toonen RF, Verhage M. Munc18–1 in secretion: lonely Munc joins SNARE team and takes control. Trends Neurosci. 2007;30:564–72.CrossRef Toonen RF, Verhage M. Munc18–1 in secretion: lonely Munc joins SNARE team and takes control. Trends Neurosci. 2007;30:564–72.CrossRef
20.
go back to reference Bennett MK, Calakos N, Scheller RH. Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science. 1992;257:255–9.CrossRef Bennett MK, Calakos N, Scheller RH. Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science. 1992;257:255–9.CrossRef
22.
go back to reference Fujiwara T, Mishima T, Kofuji T, et al. Analysis of knockout mice to determine the role of HPC-1/syntaxin 1A in expressing synaptic plasticity. J Neurosci. 2006;26:5767–76.CrossRef Fujiwara T, Mishima T, Kofuji T, et al. Analysis of knockout mice to determine the role of HPC-1/syntaxin 1A in expressing synaptic plasticity. J Neurosci. 2006;26:5767–76.CrossRef
24.
go back to reference Popugaeva E, Pchitskaya E, Bezprozvanny I, et al. Dysregulation of neuronal calcium homeostasis in Alzheimer’s disease—a therapeutic opportunity? Biochem Biophys Res Commun. 2017;483:998–1004.CrossRef Popugaeva E, Pchitskaya E, Bezprozvanny I, et al. Dysregulation of neuronal calcium homeostasis in Alzheimer’s disease—a therapeutic opportunity? Biochem Biophys Res Commun. 2017;483:998–1004.CrossRef
25.
go back to reference Nicholson RM, Kusne Y, Nowak LA, et al. Regional cerebral glucose uptake in the 3xTG model of Alzheimer’s disease highlights common regional vulnerability across AD mouse models. Brain Res. 2010;1347:179–85.CrossRef Nicholson RM, Kusne Y, Nowak LA, et al. Regional cerebral glucose uptake in the 3xTG model of Alzheimer’s disease highlights common regional vulnerability across AD mouse models. Brain Res. 2010;1347:179–85.CrossRef
26.
go back to reference Berridge MJ. Calcium regulation of neural rhythms, memory and Alzheimer’s disease. J Physiol. 2014;592:281–93.CrossRef Berridge MJ. Calcium regulation of neural rhythms, memory and Alzheimer’s disease. J Physiol. 2014;592:281–93.CrossRef
33.
go back to reference Noack R, Frede S, Albrecht P, et al. Charcot–Marie–Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potential. Hum Mol Genet. 2012;21:150–62.CrossRef Noack R, Frede S, Albrecht P, et al. Charcot–Marie–Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potential. Hum Mol Genet. 2012;21:150–62.CrossRef
34.
go back to reference Niemann A, Huber N, Wagner KM, et al. The Gdap1 knockout mouse mechanistically links redox control to Charcot–Marie–Tooth disease. Brain. 2014;137:668–82.CrossRef Niemann A, Huber N, Wagner KM, et al. The Gdap1 knockout mouse mechanistically links redox control to Charcot–Marie–Tooth disease. Brain. 2014;137:668–82.CrossRef
36.
go back to reference Segal M, Korkotian E. Roles of calcium stores and store-operated channels in plasticity of dendritic spines. Neuroscientist. 2016;22:477–85.CrossRef Segal M, Korkotian E. Roles of calcium stores and store-operated channels in plasticity of dendritic spines. Neuroscientist. 2016;22:477–85.CrossRef
37.
go back to reference Emptage NJ, Reid CA, Fine A. Calcium stores in hippocampal synaptic boutons mediate short-term plasticity, store-operated Ca2+entry, and spontaneous transmitter release. Neuron. 2001;29:197–208.CrossRef Emptage NJ, Reid CA, Fine A. Calcium stores in hippocampal synaptic boutons mediate short-term plasticity, store-operated Ca2+entry, and spontaneous transmitter release. Neuron. 2001;29:197–208.CrossRef
38.
go back to reference De Juan-Sanz J, Holt GT, Schreiter ER, et al. Axonal endoplasmic reticulum Ca2+ content controls release probability in CNS nerve terminals. Neuron. 2017;93:867-881.e6.CrossRef De Juan-Sanz J, Holt GT, Schreiter ER, et al. Axonal endoplasmic reticulum Ca2+ content controls release probability in CNS nerve terminals. Neuron. 2017;93:867-881.e6.CrossRef
39.
go back to reference Hartmann J, Karl RM, Alexander RP, et al. STIM1 controls neuronal Ca2+ signaling, mGluR1-dependent synaptic transmission, and cerebellar motor behavior. Neuron. 2014;82:635–44.CrossRef Hartmann J, Karl RM, Alexander RP, et al. STIM1 controls neuronal Ca2+ signaling, mGluR1-dependent synaptic transmission, and cerebellar motor behavior. Neuron. 2014;82:635–44.CrossRef
42.
go back to reference Nakai N, Obayashi M, Nagasaki M, et al. The abundance of mRNAs for pyruvate dehydrogenase kinase isoenzymes in brain regions of young and aged rats. Life Sci. 2000;68(5):497–503.CrossRef Nakai N, Obayashi M, Nagasaki M, et al. The abundance of mRNAs for pyruvate dehydrogenase kinase isoenzymes in brain regions of young and aged rats. Life Sci. 2000;68(5):497–503.CrossRef
44.
go back to reference Kaenmaki M, Tammimaki A, Myohanen T, et al. Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice. J Neurochem. 2010;114:1745–55.CrossRef Kaenmaki M, Tammimaki A, Myohanen T, et al. Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice. J Neurochem. 2010;114:1745–55.CrossRef
45.
go back to reference Xu H, Wang R, Zhang YW, et al. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer’s disease. Ann NY Acad Sci. 2006;1089:324–42.CrossRef Xu H, Wang R, Zhang YW, et al. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer’s disease. Ann NY Acad Sci. 2006;1089:324–42.CrossRef
46.
go back to reference Martorana A, Mori F, Esposito Z, et al. Dopamine modulates cholinergic cortical excitability in Alzheimer’s disease patients. Neuropsychopharmacology. 2011;34:2323–8.CrossRef Martorana A, Mori F, Esposito Z, et al. Dopamine modulates cholinergic cortical excitability in Alzheimer’s disease patients. Neuropsychopharmacology. 2011;34:2323–8.CrossRef
61.
go back to reference Lupo G, Gioia R, Nisi PS, et al. Molecular mechanisms of neurogenic aging in the adult mouse subventricular zone. J Exp Neurosci. 2019;13:1179069519829040.CrossRef Lupo G, Gioia R, Nisi PS, et al. Molecular mechanisms of neurogenic aging in the adult mouse subventricular zone. J Exp Neurosci. 2019;13:1179069519829040.CrossRef
62.
go back to reference Wang BJ, Her GM, Hu MK, et al. ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in Alzheimer’s disease. Proc Natl Acad Sci. 2017;114(15):E3129–38.CrossRef Wang BJ, Her GM, Hu MK, et al. ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in Alzheimer’s disease. Proc Natl Acad Sci. 2017;114(15):E3129–38.CrossRef
63.
go back to reference Wang L, Chiang HC, Wu W, et al. Epidermal growth factor receptor is a preferred target for treating amyloid-β-induced memory loss. Proc Natl Acad Sci. 2012;109(41):16743–8.CrossRef Wang L, Chiang HC, Wu W, et al. Epidermal growth factor receptor is a preferred target for treating amyloid-β-induced memory loss. Proc Natl Acad Sci. 2012;109(41):16743–8.CrossRef
68.
go back to reference Zhang S, Ju P, Tjandra E, et al. Inhibition of epidermal growth factor receptor improves myelination and attenuates tissue damage of spinal cord injury. Cell Mol Neurobiol. 2016;36(7):1169–78.CrossRef Zhang S, Ju P, Tjandra E, et al. Inhibition of epidermal growth factor receptor improves myelination and attenuates tissue damage of spinal cord injury. Cell Mol Neurobiol. 2016;36(7):1169–78.CrossRef
69.
go back to reference Qu WS, Tian DS, Guo ZB, et al. Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury. J Neuroinflam. 2012;9(1):178.CrossRef Qu WS, Tian DS, Guo ZB, et al. Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury. J Neuroinflam. 2012;9(1):178.CrossRef
71.
go back to reference Kim JH, Yoon MS, Chen J. Signal transducer and activator of transcription 3 (STAT3) mediates amino acid inhibition of insulin signalling through Serine 727 phosphorylation. J Biol Chem. 2009;284:35425–32.CrossRef Kim JH, Yoon MS, Chen J. Signal transducer and activator of transcription 3 (STAT3) mediates amino acid inhibition of insulin signalling through Serine 727 phosphorylation. J Biol Chem. 2009;284:35425–32.CrossRef
72.
go back to reference Weichhart T, et al. The TSC-mTOR signalling pathway regulates the innate inflammatory response. Immunity. 2008;29:565–77.CrossRef Weichhart T, et al. The TSC-mTOR signalling pathway regulates the innate inflammatory response. Immunity. 2008;29:565–77.CrossRef
Metadata
Title
Differential hippocampal protein expression between normal mice and mice with the perioperative neurocognitive disorder: a proteomic analysis
Authors
Chuan Li
Jingzhu Li
He Tao
Jinghua Shan
Fanghao Liu
Xiyuan Deng
Yanan Lin
Xu Lin
Li Fu
Bin Wang
Yanlin Bi
Publication date
01-12-2021
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2021
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-021-00599-3

Other articles of this Issue 1/2021

European Journal of Medical Research 1/2021 Go to the issue